Loading...
OTC Markets
Totals
Securities
12,253
Dollar Vol
$1.2B
Share Vol
2.6B
Trades
147,961

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

RHHBF
Roche Holding Ltd

Ordinary Shares - Bearer Shares

319.50

-12.8865

-3.88%

319.50 / 337.15 (7 x 1)

Real-Time Best Bid & Ask: 11:20am 08/06/2025
Delayed (15 Min) Trade Data: 10:35am 08/06/2025

319.50

319.50 - 319.50

2

Market Cap calculated only for this class of securities.

53,411,519,072

Real-Time Level 2 Quote
Bid
Ask
MPID
MPID
Bid Price
Bid Price
Size
Size
Time
Time
VIRTU Americas LLC
NITE
319.50709:30
StoneX Financial Inc.
INTL
316.50111:59
G1 Execution Services, LLC
ETRF
315.00112:20
MCAP LLC
MCAP
305.68512:38
Citadel Securities
CDEL
300.007009:30
MPID
MPID
Ask Price
Ask Price
Size
Size
Time
Time
G1 Execution Services, LLC
ETRF
337.15111:00
StoneX Financial Inc.
INTL
338.34111:59
MCAP LLC
MCAP
342.82512:38
Citadel Securities
CDEL
352.0014609:30
CANACCORD GENUITY LLC.
CSTI
370.50109:21
More
Trade Data
Date
Date
Timestamp
Timestamp
Price
Price
$ Change
$ Change
Volume
Volume
08/06/202510:35:26
319.50
-12.892
08/05/202511:37:29
332.3865
-0.6174
08/01/202515:56:03
333.00
0.0040
08/01/202515:51:49
333.00
-0.3355
08/01/202509:44:13
333.33
-43.678
More Irregular/odd lot trades, which are not considered for the Open, High, Low or Closing prices, are not shown in trade data table.
Filings and Disclosure
Company Description
Founded in1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalized healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice. In recognizing our endeavor to pursue a long-term perspective in all we do, Roche has been named one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices for the thirteenth consecutive year. This distinction also reflects our efforts to improve access to healthcare together with local partners in every country we work. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.
Videos

This company has not added any videos

OTCQX Best Market Logo
Joined OTCQX 10/2015
The Company Profile data was verified by the issuer within the previous 6 months.
This security is not a Penny Stock as defined in SEC Rule 240.3a51-1.
This company has certified to OTC Markets Group that it is eligible to rely on the exemption from registration under Securities and Exchange Act Rule 12g3-2(b).
Securities
Other Roche Holding Ltd Securities
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.